Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration.
Qing WeiTeng YangJiayu ZhuZiwen ZhangLe YangYuchao ZhangXiang-Dong ChengJiahui ChenJinchao WangXuefei TianTakaya ShimuraJianmin FangJie-Er YingMengyang FanPeng GuoXiangdong ChengPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
These promising preclinical data allowed us to initiate a phase I/II clinical study of coadministration of RC48 and trastuzumab in patients with malignant stomach cancer to further evaluate this treatment strategy in humans.